Apollomics Total Debt vs. Net Income

APLM Stock   8.35  0.12  1.46%   
Based on Apollomics' profitability indicators, Apollomics Class A may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Apollomics' ability to earn profits and add value for shareholders. At this time, Apollomics' Days Sales Outstanding is very stable compared to the past year. As of the 10th of December 2024, Days Of Sales Outstanding is likely to grow to 242.06, while Price To Sales Ratio is likely to drop 8,307. At this time, Apollomics' Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 10th of December 2024, Net Interest Income is likely to grow to about 633.1 K, while Operating Income is likely to drop (57.6 M).
For Apollomics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Apollomics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Apollomics Class A utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Apollomics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Apollomics Class A over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
0.023
Quarterly Revenue Growth
2.623
Return On Assets
(0.63)
Return On Equity
(1.49)
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Apollomics Class A Net Income vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Apollomics's current stock value. Our valuation model uses many indicators to compare Apollomics value to that of its competitors to determine the firm's financial worth.
Apollomics Class A is the top company in total debt category among its peers. It also is number one stock in net income category among its peers . Apollomics reported last year Net Loss of (172.6 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Apollomics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Apollomics Total Debt vs. Competition

Apollomics Class A is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 19.13 Billion. Apollomics adds roughly 4.66 Million in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Capitalization  Valuation  Revenue  Workforce

Apollomics Net Income vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Apollomics

Total Debt

 = 

Bonds

+

Notes

 = 
4.66 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Apollomics

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(172.59 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Apollomics Net Income Comparison

Apollomics is currently under evaluation in net income category among its peers.

Apollomics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Apollomics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Apollomics will eventually generate negative long term returns. The profitability progress is the general direction of Apollomics' change in net profit over the period of time. It can combine multiple indicators of Apollomics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income26.7 M28.1 M
Net Interest Income603 K633.1 K
Interest Income753 K544.8 K
Operating Income-54.8 M-57.6 M
Net Loss-172.6 M-181.2 M
Income Before Tax-172.6 M-181.2 M
Total Other Income Expense Net-117.8 M-123.6 M
Net Loss-172.6 M-181.2 M
Income Tax Expense10 K10.5 K
Net Loss(2.32)(2.44)
Income Quality 0.25  0.41 
Net Income Per E B T 1.00  1.10 

Apollomics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Apollomics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Apollomics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Apollomics' important profitability drivers and their relationship over time.

Use Apollomics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apollomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will appreciate offsetting losses from the drop in the long position's value.

Apollomics Pair Trading

Apollomics Class A Pair Trading Analysis

The ability to find closely correlated positions to Apollomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apollomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apollomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apollomics Class A to buy it.
The correlation of Apollomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apollomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apollomics Class A moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apollomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Apollomics position

In addition to having Apollomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Global Macro ETFs Thematic Idea Now

Global Macro ETFs
Global Macro ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Apollomics Class A is a strong investment it is important to analyze Apollomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apollomics' future performance. For an informed investment choice regarding Apollomics Stock, refer to the following important reports:
Check out Trending Equities.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
To fully project Apollomics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Apollomics Class A at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Apollomics' income statement, its balance sheet, and the statement of cash flows.
Potential Apollomics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Apollomics investors may work on each financial statement separately, they are all related. The changes in Apollomics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Apollomics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.